We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+20.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
-$19M
Cap. Flow
-$29.1M
Cap. Flow %
-14.57%
Top 10 Hldgs %
5.74%
Holding
864
New
212
Increased
98
Reduced
280
Closed
274

Top Buys

Rank Stock Value
1
BR icon
Broadridge
BR
+$1.44M
2
RBC icon
RBC Bearings
RBC
+$1.16M
3
RCKT icon
Rocket Pharmaceuticals
RCKT
+$1.14M
4
CMCSA icon
Comcast
CMCSA
+$1.08M
5
CAT icon
Caterpillar
CAT
+$984K

Sector Composition

Rank Sector Weight
1 Industrials 17.08%
2 Technology 16.79%
3 Financials 15.55%
4 Healthcare 14.47%
5 Consumer Discretionary 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOLD
351
DELISTED
Amicus Therapeutics
FOLD
$261K 0.13%
+45,496
New +$294K
SIBN icon
352
SI-BONE Inc
SIBN
$737M
$260K 0.13%
13,827
-960
-6% -$15.9K
NEO icon
353
NeoGenomics
NEO
$1.82B
$259K 0.13%
+35,490
New +$286K
PEP icon
354
PepsiCo
PEP
$187B
$259K 0.13%
+1,960
New +$264K
CHDN icon
355
Churchill Downs
CHDN
$6.01B
$259K 0.13%
+2,561
New +$251K
ACVA icon
356
ACV Auctions
ACVA
$1.35B
$258K 0.13%
15,897
-20,884
-57% -$325K
CLPT icon
357
ClearPoint Neuro
CLPT
$426M
$258K 0.13%
21,586
-14,496
-40% -$182K
WWD icon
358
Woodward
WWD
$24.9B
$257K 0.13%
+1,049
New +$215K
MEDP icon
359
Medpace
MEDP
$16.9B
$257K 0.13%
819
-31
-4% -$9.31K
DMRC icon
360
Digimarc Corp
DMRC
$136M
$257K 0.13%
19,433
+9,243
+91% +$119K
BMRN icon
361
BioMarin Pharmaceuticals
BMRN
$11.4B
$256K 0.13%
+4,662
New +$275K
DORM icon
362
Dorman Products
DORM
$3.97B
$256K 0.13%
2,088
-80
-4% -$9.73K
JBI icon
363
Janus International
JBI
$724M
$256K 0.13%
31,438
+5,097
+19% +$38.9K
TRMK icon
364
Trustmark
TRMK
$2.73B
$256K 0.13%
+7,018
New +$240K
AMN icon
365
AMN Healthcare
AMN
$1.28B
$254K 0.13%
12,302
-10,577
-46% -$220K
TXT icon
366
Textron
TXT
$16.6B
$254K 0.13%
3,164
-122
-4% -$8.83K
BFLY icon
367
Butterfly Network
BFLY
$1.72B
$254K 0.13%
126,999
+79,284
+166% +$182K
MEC icon
368
Mayville Engineering Co
MEC
$767M
$254K 0.13%
15,914
-577
-3% -$8.24K
CPRX
369
DELISTED
Catalyst Pharmaceutical
CPRX
$253K 0.13%
11,666
-449
-4% -$10.6K
MMSI icon
370
Merit Medical Systems
MMSI
$4.43B
$253K 0.13%
2,702
-104
-4% -$9.85K
GRC icon
371
Gorman-Rupp
GRC
$2.15B
$252K 0.13%
+6,852
New +$246K
LAND
372
Gladstone Land Corp
LAND
$370M
$252K 0.13%
24,738
-828
-3% -$8.13K
VEEV icon
373
Veeva Systems
VEEV
$30.3B
$251K 0.13%
+872
New +$216K
TCBX icon
374
Third Coast Bancshares
TCBX
$709M
$251K 0.13%
+7,686
New +$234K
BV icon
375
BrightView Holdings
BV
$1.32B
$251K 0.13%
+15,068
New +$225K

Similar funds

EntryPoint Capital's Q2 2025 Portfolio in Review

As of Q2 2025, EntryPoint Capital held 864 positions worth $200M, down 8.7% from $218M the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.

EntryPoint Capital withdrew a net $29.1M in Q2 2025, closing 274 positions and reducing 280 holdings. Its most notable exit was Universal Technical Institute, an estimated $921K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, EntryPoint Capital opened a new position in Broadridge worth $1.47M.

  • EntryPoint Capital's largest Q2 2025 buy was Broadridge: 6,049 shares worth $1.47M.
  • EntryPoint Capital added most to Rocket Pharmaceuticals in Q2 2025, an estimated $1.14M increase.
  • EntryPoint Capital's biggest Q2 2025 reduction was Trimble, cutting an estimated $714K.
  • EntryPoint Capital fully exited Universal Technical Institute in Q2 2025, selling an estimated $921K.
  • EntryPoint Capital's ten largest holdings make up 5.7% of its $200M portfolio in Q2 2025.
  • EntryPoint Capital opened 212 new positions and closed 274 in Q2 2025.
  • EntryPoint Capital's portfolio value fell 8.7% quarter-over-quarter to $200M.

Based on EntryPoint Capital's 13F filing for Q2 2025, filed 11 Aug 2025.